Exposure to new environments and diseases can put travellers at an increased risk of serious illness. Travel vaccines against diseases such as hepatitis A and B, rabies, typhoid and cholera
LPI (LP Information)' newest research report, the “Travel Vaccines Industry Forecast” looks at past sales and reviews total world Travel Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Travel Vaccines sales for 2023 through 2029. With Travel Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Travel Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Travel Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Travel Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Travel Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Travel Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Travel Vaccines.
The global Travel Vaccines market size is projected to grow from US$ 5350.1 million in 2022 to US$ 9273.4 million in 2029; it is expected to grow at a CAGR of 9273.4 from 2023 to 2029.
United States market for Travel Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Travel Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Travel Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Travel Vaccines players cover GSK, Sanofi, Merck, Pfizer, Jintan, CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Travel Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Cholera
Rabies Vaccine
Hepatitis
Typhoid
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
Sanofi
Merck
Pfizer
Jintan
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Key Questions Addressed in this Report
What is the 10-year outlook for the global Travel Vaccines market?
What factors are driving Travel Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Travel Vaccines market opportunities vary by end market size?
How does Travel Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Travel Vaccines Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Travel Vaccines by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Travel Vaccines by Country/Region, 2018, 2022 & 2029 2.2 Travel Vaccines Segment by Type 2.2.1 Cholera 2.2.2 Rabies Vaccine 2.2.3 Hepatitis 2.2.4 Typhoid 2.3 Travel Vaccines Sales by Type 2.3.1 Global Travel Vaccines Sales Market Share by Type (2018-2023) 2.3.2 Global Travel Vaccines Revenue and Market Share by Type (2018-2023) 2.3.3 Global Travel Vaccines Sale Price by Type (2018-2023) 2.4 Travel Vaccines Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.5 Travel Vaccines Sales by Application 2.5.1 Global Travel Vaccines Sale Market Share by Application (2018-2023) 2.5.2 Global Travel Vaccines Revenue and Market Share by Application (2018-2023) 2.5.3 Global Travel Vaccines Sale Price by Application (2018-2023) 3 Global Travel Vaccines by Company 3.1 Global Travel Vaccines Breakdown Data by Company 3.1.1 Global Travel Vaccines Annual Sales by Company (2018-2023) 3.1.2 Global Travel Vaccines Sales Market Share by Company (2018-2023) 3.2 Global Travel Vaccines Annual Revenue by Company (2018-2023) 3.2.1 Global Travel Vaccines Revenue by Company (2018-2023) 3.2.2 Global Travel Vaccines Revenue Market Share by Company (2018-2023) 3.3 Global Travel Vaccines Sale Price by Company 3.4 Key Manufacturers Travel Vaccines Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Travel Vaccines Product Location Distribution 3.4.2 Players Travel Vaccines Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Travel Vaccines by Geographic Region 4.1 World Historic Travel Vaccines Market Size by Geographic Region (2018-2023) 4.1.1 Global Travel Vaccines Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Travel Vaccines Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Travel Vaccines Market Size by Country/Region (2018-2023) 4.2.1 Global Travel Vaccines Annual Sales by Country/Region (2018-2023) 4.2.2 Global Travel Vaccines Annual Revenue by Country/Region (2018-2023) 4.3 Americas Travel Vaccines Sales Growth 4.4 APAC Travel Vaccines Sales Growth 4.5 Europe Travel Vaccines Sales Growth 4.6 Middle East & Africa Travel Vaccines Sales Growth 5 Americas 5.1 Americas Travel Vaccines Sales by Country 5.1.1 Americas Travel Vaccines Sales by Country (2018-2023) 5.1.2 Americas Travel Vaccines Revenue by Country (2018-2023) 5.2 Americas Travel Vaccines Sales by Type 5.3 Americas Travel Vaccines Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Travel Vaccines Sales by Region 6.1.1 APAC Travel Vaccines Sales by Region (2018-2023) 6.1.2 APAC Travel Vaccines Revenue by Region (2018-2023) 6.2 APAC Travel Vaccines Sales by Type 6.3 APAC Travel Vaccines Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Travel Vaccines by Country 7.1.1 Europe Travel Vaccines Sales by Country (2018-2023) 7.1.2 Europe Travel Vaccines Revenue by Country (2018-2023) 7.2 Europe Travel Vaccines Sales by Type 7.3 Europe Travel Vaccines Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Travel Vaccines by Country 8.1.1 Middle East & Africa Travel Vaccines Sales by Country (2018-2023) 8.1.2 Middle East & Africa Travel Vaccines Revenue by Country (2018-2023) 8.2 Middle East & Africa Travel Vaccines Sales by Type 8.3 Middle East & Africa Travel Vaccines Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Travel Vaccines 10.3 Manufacturing Process Analysis of Travel Vaccines 10.4 Industry Chain Structure of Travel Vaccines 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Travel Vaccines Distributors 11.3 Travel Vaccines Customer 12 World Forecast Review for Travel Vaccines by Geographic Region 12.1 Global Travel Vaccines Market Size Forecast by Region 12.1.1 Global Travel Vaccines Forecast by Region (2024-2029) 12.1.2 Global Travel Vaccines Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Travel Vaccines Forecast by Type 12.7 Global Travel Vaccines Forecast by Application 13 Key Players Analysis 13.1 GSK 13.1.1 GSK Company Information 13.1.2 GSK Travel Vaccines Product Portfolios and Specifications 13.1.3 GSK Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 GSK Main Business Overview 13.1.5 GSK Latest Developments 13.2 Sanofi 13.2.1 Sanofi Company Information 13.2.2 Sanofi Travel Vaccines Product Portfolios and Specifications 13.2.3 Sanofi Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Sanofi Main Business Overview 13.2.5 Sanofi Latest Developments 13.3 Merck 13.3.1 Merck Company Information 13.3.2 Merck Travel Vaccines Product Portfolios and Specifications 13.3.3 Merck Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Merck Main Business Overview 13.3.5 Merck Latest Developments 13.4 Pfizer 13.4.1 Pfizer Company Information 13.4.2 Pfizer Travel Vaccines Product Portfolios and Specifications 13.4.3 Pfizer Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Pfizer Main Business Overview 13.4.5 Pfizer Latest Developments 13.5 Jintan 13.5.1 Jintan Company Information 13.5.2 Jintan Travel Vaccines Product Portfolios and Specifications 13.5.3 Jintan Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Jintan Main Business Overview 13.5.5 Jintan Latest Developments 13.6 CSL 13.6.1 CSL Company Information 13.6.2 CSL Travel Vaccines Product Portfolios and Specifications 13.6.3 CSL Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 CSL Main Business Overview 13.6.5 CSL Latest Developments 13.7 MedImmune LLC 13.7.1 MedImmune LLC Company Information 13.7.2 MedImmune LLC Travel Vaccines Product Portfolios and Specifications 13.7.3 MedImmune LLC Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 MedImmune LLC Main Business Overview 13.7.5 MedImmune LLC Latest Developments 13.8 J&J(Crucell) 13.8.1 J&J(Crucell) Company Information 13.8.2 J&J(Crucell) Travel Vaccines Product Portfolios and Specifications 13.8.3 J&J(Crucell) Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 J&J(Crucell) Main Business Overview 13.8.5 J&J(Crucell) Latest Developments 13.9 China National Biotec 13.9.1 China National Biotec Company Information 13.9.2 China National Biotec Travel Vaccines Product Portfolios and Specifications 13.9.3 China National Biotec Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 China National Biotec Main Business Overview 13.9.5 China National Biotec Latest Developments 13.10 Tiantan 13.10.1 Tiantan Company Information 13.10.2 Tiantan Travel Vaccines Product Portfolios and Specifications 13.10.3 Tiantan Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Tiantan Main Business Overview 13.10.5 Tiantan Latest Developments 13.11 Hualan 13.11.1 Hualan Company Information 13.11.2 Hualan Travel Vaccines Product Portfolios and Specifications 13.11.3 Hualan Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Hualan Main Business Overview 13.11.5 Hualan Latest Developments 13.12 Kangtai 13.12.1 Kangtai Company Information 13.12.2 Kangtai Travel Vaccines Product Portfolios and Specifications 13.12.3 Kangtai Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Kangtai Main Business Overview 13.12.5 Kangtai Latest Developments 13.13 Hissen 13.13.1 Hissen Company Information 13.13.2 Hissen Travel Vaccines Product Portfolios and Specifications 13.13.3 Hissen Travel Vaccines Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Hissen Main Business Overview 13.13.5 Hissen Latest Developments 14 Research Findings and Conclusion